# BigBear.ai Holdings, Inc.: financial statements, quarterly

BBAI · NYSE · CIK 1836981 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bbai.md) · [Financials](/companies/bbai/financials.md) · [Filings](/companies/bbai/filings.md) · [Insiders](/companies/bbai/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bbai/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [34.0](/filings/0001628280-25-014752.md) | [40.6](/filings/0001628280-25-014752.md) | [33.1](/filings/0001628280-25-021899.md) | [39.8](/filings/0001628280-25-039629.md) | [41.5](/filings/0001836981-25-000028.md) | [43.8 d](/filings/0001836981-26-000018.md) | [34.8](/filings/0001836981-26-000049.md) | [32.5](/filings/0001836981-26-000064.md) | [33.1](/filings/0001836981-25-000028.md) | [27.3 d](/filings/0001836981-26-000018.md) | [34.4](/filings/0001836981-26-000049.md) | [36.7](/filings/0001836981-26-000064.md) |
| Cost of revenue | $m | [25.6](/filings/0001628280-25-014752.md) | [27.5](/filings/0001628280-25-014752.md) | [26.1](/filings/0001628280-25-021899.md) | [28.7](/filings/0001628280-25-039629.md) | [30.7](/filings/0001836981-25-000028.md) | [27.4 d](/filings/0001836981-26-000018.md) | [27.4](/filings/0001836981-26-000049.md) | [24.4](/filings/0001836981-26-000064.md) | [25.7](/filings/0001836981-25-000028.md) | [21.8 d](/filings/0001836981-26-000018.md) | [22.7](/filings/0001836981-26-000049.md) | [24.7](/filings/0001836981-26-000064.md) |
| Gross profit | $m | [8.4](/filings/0001628280-25-014752.md) | [13.0](/filings/0001628280-25-014752.md) | [7.0](/filings/0001628280-25-021899.md) | [11.1](/filings/0001628280-25-039629.md) | [10.8](/filings/0001836981-25-000028.md) | [16.4 d](/filings/0001836981-26-000018.md) | [7.4](/filings/0001836981-26-000049.md) | [8.1](/filings/0001836981-26-000064.md) | [7.4](/filings/0001836981-25-000028.md) | [5.5 d](/filings/0001836981-26-000018.md) | [11.7](/filings/0001836981-26-000049.md) | [12.1](/filings/0001836981-26-000064.md) |
| Research and development | $m | [(0.3)](/filings/0001628280-23-038308.md) | [2.0 d](/filings/0001836981-26-000018.md) | [1.1](/filings/0001628280-24-022622.md) | [3.6](/filings/0001628280-25-039629.md) | [3.8](/filings/0001836981-25-000028.md) | [2.3 d](/filings/0001836981-26-000018.md) | [4.2](/filings/0001836981-26-000049.md) | [4.4](/filings/0001836981-26-000064.md) | [3.4](/filings/0001836981-25-000028.md) | [4.8 d](/filings/0001836981-26-000018.md) | [5.5](/filings/0001836981-26-000049.md) | [7.6](/filings/0001836981-26-000064.md) |
| Selling, general and administrative | $m | [15.5](/filings/0001628280-25-014752.md) | [18.2](/filings/0001628280-25-014752.md) | [16.9](/filings/0001628280-25-021899.md) | [23.4](/filings/0001628280-25-039629.md) | [17.5](/filings/0001836981-25-000028.md) | [22.2 d](/filings/0001836981-26-000018.md) | [22.7](/filings/0001836981-26-000049.md) | [21.5](/filings/0001836981-26-000064.md) | [25.3](/filings/0001836981-25-000028.md) | [25.7 d](/filings/0001836981-26-000018.md) | [29.2](/filings/0001836981-26-000049.md) | [31.8](/filings/0001836981-26-000064.md) |
| Operating income | $m | [(8.2)](/filings/0001628280-25-014752.md) | [(8.6)](/filings/0001628280-25-014752.md) | [(98.1)](/filings/0001628280-25-021899.md) | [(16.7)](/filings/0001628280-25-039629.md) | [(10.5)](/filings/0001836981-25-000028.md) | [(8.1) d](/filings/0001836981-26-000018.md) | [(21.2)](/filings/0001836981-26-000049.md) | [(90.3)](/filings/0001836981-26-000064.md) | [(21.9)](/filings/0001836981-25-000028.md) | [(80.5) d](/filings/0001836981-26-000018.md) | [(24.3)](/filings/0001836981-26-000049.md) | [(28.6)](/filings/0001836981-26-000064.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.0)](/filings/0001628280-25-014752.md) | [(0.3)](/filings/0001628280-25-014752.md) | [(0.0)](/filings/0001628280-25-021899.md) | [0.0](/filings/0001628280-25-039629.md) | [0.0](/filings/0001836981-25-000028.md) | [(0.3) d](/filings/0001836981-26-000018.md) | [0.0](/filings/0001836981-26-000049.md) | [0.0](/filings/0001836981-26-000064.md) | [0.0](/filings/0001836981-25-000028.md) | [(21.8) d](/filings/0001836981-26-000018.md) | [0.0](/filings/0001836981-26-000049.md) | [0.0](/filings/0001836981-26-000064.md) |
| Net income | $m | [2.9](/filings/0001628280-25-014752.md) | [(23.5)](/filings/0001628280-25-014752.md) | [(128)](/filings/0001628280-25-021899.md) | [(14.4)](/filings/0001628280-25-039629.md) | [(15.1)](/filings/0001836981-25-000028.md) | [(138) d](/filings/0001836981-26-000018.md) | [(62.0)](/filings/0001836981-26-000049.md) | [(229)](/filings/0001836981-26-000064.md) | [2.5](/filings/0001836981-25-000028.md) | [(5.8) d](/filings/0001836981-26-000018.md) | [(56.8)](/filings/0001836981-26-000049.md) | [(25.7)](/filings/0001836981-26-000064.md) |
| Diluted EPS | $ per share | [0.02](/filings/0001628280-25-014752.md) | [(0.15)](/filings/0001628280-25-014752.md) | [(0.68)](/filings/0001628280-25-021899.md) | [(0.06)](/filings/0001628280-25-039629.md) | [(0.06)](/filings/0001836981-25-000028.md) | not reported | [(0.25)](/filings/0001836981-26-000049.md) | [(0.71)](/filings/0001836981-26-000064.md) | [(0.03)](/filings/0001836981-25-000028.md) | not reported | [(0.12)](/filings/0001836981-26-000049.md) | [(0.05)](/filings/0001836981-26-000064.md) |
| Basic EPS | $ per share | [0.02](/filings/0001628280-25-014752.md) | [(0.15)](/filings/0001628280-25-014752.md) | [(0.68)](/filings/0001628280-25-021899.md) | [(0.06)](/filings/0001628280-25-039629.md) | [(0.06)](/filings/0001836981-25-000028.md) | not reported | [(0.25)](/filings/0001836981-26-000049.md) | [(0.71)](/filings/0001836981-26-000064.md) | [0.01](/filings/0001836981-25-000028.md) | not reported | [(0.12)](/filings/0001836981-26-000049.md) | [(0.05)](/filings/0001836981-26-000064.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [32.2](/filings/0001628280-25-014752.md) | [32.6](/filings/0001836981-26-000018.md) | [81.4](/filings/0001628280-25-014752.md) | [72.3](/filings/0001628280-25-014752.md) | [65.6](/filings/0001628280-25-014752.md) | [50.1](/filings/0001836981-26-000018.md) | [108](/filings/0001628280-25-021899.md) | [391](/filings/0001628280-25-039629.md) | [457](/filings/0001836981-25-000028.md) | [87.1](/filings/0001836981-26-000064.md) | [101](/filings/0001836981-26-000049.md) | [36.3](/filings/0001836981-26-000064.md) |
| Current assets | $m | [65.8](/filings/0001628280-25-014752.md) | [63.8](/filings/0001628280-25-014752.md) | [125](/filings/0001628280-25-014752.md) | [112](/filings/0001628280-25-014752.md) | [104](/filings/0001628280-25-014752.md) | [93.8](/filings/0001836981-26-000018.md) | [148](/filings/0001628280-25-021899.md) | [424](/filings/0001628280-25-039629.md) | [620](/filings/0001836981-25-000028.md) | [331](/filings/0001836981-26-000064.md) | [394](/filings/0001836981-26-000049.md) | [373](/filings/0001836981-26-000064.md) |
| Total assets | $m | [203](/filings/0001628280-25-014752.md) | [200](/filings/0001628280-25-014752.md) | [378](/filings/0001628280-25-014752.md) | [361](/filings/0001628280-25-014752.md) | [354](/filings/0001628280-25-014752.md) | [344](/filings/0001836981-26-000018.md) | [396](/filings/0001628280-25-021899.md) | [599](/filings/0001628280-25-039629.md) | [920](/filings/0001836981-25-000028.md) | [895](/filings/0001836981-26-000064.md) | [862](/filings/0001836981-26-000049.md) | [841](/filings/0001836981-26-000064.md) |
| Current liabilities | $m | [57.7](/filings/0001628280-25-014752.md) | [69.1](/filings/0001628280-25-014752.md) | [63.4](/filings/0001628280-25-014752.md) | [53.4](/filings/0001628280-25-014752.md) | [50.6](/filings/0001628280-25-014752.md) | [203](/filings/0001836981-26-000018.md) | [89.1](/filings/0001628280-25-021899.md) | [222](/filings/0001628280-25-039629.md) | [198](/filings/0001836981-25-000028.md) | [186](/filings/0001836981-26-000064.md) | [64.8](/filings/0001836981-26-000049.md) | [65.7](/filings/0001836981-26-000064.md) |
| Total liabilities | $m | [216](/filings/0001628280-25-014752.md) | [230](/filings/0001628280-25-014752.md) | [234](/filings/0001628280-25-014752.md) | [226](/filings/0001628280-25-014752.md) | [227](/filings/0001628280-25-014752.md) | [347](/filings/0001836981-26-000018.md) | [198](/filings/0001628280-25-021899.md) | [333](/filings/0001628280-25-039629.md) | [310](/filings/0001836981-25-000028.md) | [283](/filings/0001836981-26-000064.md) | [71.3](/filings/0001836981-26-000049.md) | [71.0](/filings/0001836981-26-000064.md) |
| Long-term debt | $m | [153](/filings/0001628280-25-014752.md) | [156](/filings/0001628280-25-014752.md) | [159](/filings/0001628280-25-014752.md) | [163](/filings/0001628280-25-014752.md) | [166](/filings/0001628280-25-014752.md) | [135](/filings/0001836981-26-000018.md) | [101](/filings/0001628280-25-021899.md) | [103](/filings/0001628280-25-039629.md) | [105](/filings/0001836981-25-000028.md) | [90.5](/filings/0001836981-26-000064.md) | [0.0](/filings/0001836981-26-000049.md) | [0.0](/filings/0001836981-26-000064.md) |
| Current portion of debt | $m | [0.0](/filings/0001628280-23-038308.md) | [1.2](/filings/0001628280-25-014752.md) | [0.8](/filings/0001628280-24-022622.md) | [0.4](/filings/0001628280-24-036497.md) | [0.0](/filings/0001628280-24-046327.md) | [0.8](/filings/0001836981-26-000018.md) | [0.8](/filings/0001628280-25-021899.md) | [0.4](/filings/0001628280-25-039629.md) | [0.0](/filings/0001836981-25-000028.md) | [16.6](/filings/0001836981-26-000064.md) | [16.6](/filings/0001836981-26-000049.md) | [16.6](/filings/0001836981-26-000064.md) |
| Shareholders' equity | $m | [(12.7)](/filings/0001628280-25-014752.md) | [(30.0)](/filings/0001836981-26-000018.md) | [143](/filings/0001628280-25-039629.md) | [135](/filings/0001836981-25-000028.md) | [127](/filings/0001836981-25-000028.md) | [(3.7)](/filings/0001836981-26-000064.md) | [198](/filings/0001836981-26-000064.md) | [267](/filings/0001836981-26-000064.md) | [610](/filings/0001836981-25-000028.md) | [612](/filings/0001836981-26-000064.md) | [790](/filings/0001836981-26-000064.md) | [770](/filings/0001836981-26-000064.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [6.6 d](/filings/0001628280-25-014752.md) | [(0.1) d](/filings/0001836981-26-000018.md) | [(14.4)](/filings/0001628280-25-021899.md) | [(7.1) d](/filings/0001628280-25-039629.md) | [(1.9) d](/filings/0001836981-25-000028.md) | [(14.8) d](/filings/0001836981-26-000018.md) | [(6.7)](/filings/0001836981-26-000049.md) | [(3.9) d](/filings/0001836981-26-000064.md) | [(9.6) d](/filings/0001836981-25-000028.md) | [(21.8) d](/filings/0001836981-26-000018.md) | [(18.0)](/filings/0001836981-26-000049.md) | [(22.2) d](/filings/0001836981-26-000064.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001628280-25-014752.md) | [0.0 d](/filings/0001836981-26-000018.md) | [0.0](/filings/0001628280-25-021899.md) | [0.1 d](/filings/0001628280-25-039629.md) | [0.1 d](/filings/0001836981-25-000028.md) | [0.2 d](/filings/0001836981-26-000018.md) | [0.1](/filings/0001836981-26-000049.md) | [0.0 d](/filings/0001836981-26-000064.md) | [0.2 d](/filings/0001836981-25-000028.md) | [0.3 d](/filings/0001836981-26-000018.md) | [0.3](/filings/0001836981-26-000049.md) | [0.3 d](/filings/0001836981-26-000064.md) |
| Share repurchases | $m | [0.0 d](/filings/0001628280-23-038308.md) | [0.0 d](/filings/0001628280-25-014752.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [126](/filings/0001628280-23-038308.md) | [139](/filings/0001628280-24-022622.md) | [145](/filings/0001628280-24-036497.md) | [158](/filings/0001628280-24-046327.md) | [187](/filings/0001628280-25-021899.md) | [246](/filings/0001628280-25-039629.md) | [250](/filings/0001836981-25-000028.md) | [252](/filings/0001836981-26-000049.md) | [321](/filings/0001836981-26-000064.md) | [448](/filings/0001836981-25-000028.md) | [473](/filings/0001836981-26-000049.md) | [479](/filings/0001836981-26-000064.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 479,494,493 at 2026-06-30, from the cover of the [10-Q filed 2026-07-30](/filings/0001836981-26-000064.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.